Symbols / XBIT $2.32 -1.28% XBiotech Inc.

Healthcare • Biotechnology • United States • NMS
XBIT Chart
About

XBiotech Inc., a biopharmaceutical company, discovers, and develops, True Human monoclonal antibodies for treating various diseases. It develops a pipeline of product candidates targeting inflammatory and infectious diseases. The company is also developing interleukin-1 alpha therapies to various medical conditions, such as cancer, stroke, heart attack, or arthritis; and mediates tissue breakdown, angiogenesis, the formation of blood clots, malaise, muscle wasting, and general inflammation. The company was incorporated in 2005 and is headquartered in Austin, Texas.

Fundamentals
Scroll to Statements
Sector Healthcare Industry Biotechnology Market Cap 70.73M
Enterprise Value -53.90M Income -45.54M Sales —
Book/sh 4.60 Cash/sh 4.12 Dividend Yield —
Payout 0.00% Employees 85 IPO —
P/E — Forward P/E 17.85 PEG —
P/S — P/B 0.50 P/C —
EV/EBITDA 1.00 EV/Sales — Quick Ratio 15.88
Current Ratio 16.01 Debt/Eq — LT Debt/Eq —
EPS (ttm) -1.49 EPS next Y 0.13 EPS Growth —
Revenue Growth — Earnings 2020-05-11 17:00 ROA -19.93%
ROE -28.23% ROIC — Gross Margin 0.00%
Oper. Margin 0.00% Profit Margin 0.00% Shs Outstand 30.49M
Shs Float 19.09M Short Float 0.62% Short Ratio 4.54
Short Interest — 52W High 3.62 52W Low 2.09
Beta 0.83 Avg Volume 43.15K Volume 19.68K
Target Price — Recom None Prev Close $2.35
Price $2.32 Change -1.28%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
—
Mean price target
2. Current target
$2.32
Latest analyst target
3. DCF / Fair value
$-15.51
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$2.32
Low
—
High
—
Mean
—

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2020-04-07 main Piper Sandler — → Overweight $18
2019-12-11 main Piper Sandler — → Overweight $28
2019-06-14 init Piper Sandler — → Overweight $13
News
RSS: Latest XBIT news
Insider Transactions

No recent insider transactions.

Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
0.00
0.00
0.00
-100.00%
4.01
Operating Revenue
0.00
0.00
0.00
-100.00%
4.01
Cost Of Revenue
—
—
0.00
-100.00%
0.65
Reconciled Cost Of Revenue
—
—
0.00
-100.00%
0.65
Gross Profit
—
—
0.00
-100.00%
3.36
Operating Expense
55.69
+31.11%
42.47
+13.23%
37.51
-0.90%
37.85
Research And Development
47.39
+25.51%
37.76
+14.94%
32.85
+4.13%
31.54
Selling General And Administration
8.29
+75.97%
4.71
+1.12%
4.66
-26.06%
6.30
General And Administrative Expense
8.29
+75.97%
4.71
+1.12%
4.66
-26.06%
6.30
Salaries And Wages
5.45
+153.53%
2.15
+23.14%
1.75
-55.40%
3.92
Other Gand A
2.84
+10.92%
2.56
-12.07%
2.92
+22.01%
2.39
Total Expenses
55.69
+31.11%
42.47
+13.23%
37.51
-2.57%
38.50
Operating Income
-55.69
-31.11%
-42.47
-13.23%
-37.51
-8.76%
-34.49
Total Operating Income As Reported
-55.69
-31.11%
-42.47
-13.23%
-37.51
-8.76%
-34.49
EBITDA
-43.53
-20.88%
-36.01
-59.56%
-22.57
+29.20%
-31.88
Normalized EBITDA
-46.86
-53.74%
-30.48
-24.61%
-24.46
+15.87%
-29.08
Reconciled Depreciation
1.69
-3.38%
1.75
+0.06%
1.74
-33.28%
2.61
EBIT
-45.22
-19.76%
-37.76
-55.29%
-24.31
+29.51%
-34.49
Total Unusual Items
3.33
+160.28%
-5.53
-392.08%
1.89
+167.61%
-2.80
Total Unusual Items Excluding Goodwill
3.33
+160.28%
-5.53
-392.08%
1.89
+167.61%
-2.80
Special Income Charges
—
—
—
—
Net Income
-45.54
-18.19%
-38.53
-56.90%
-24.56
+25.36%
-32.90
Pretax Income
-45.30
-17.48%
-38.56
-58.61%
-24.31
+27.61%
-33.59
Net Non Operating Interest Income Expense
5.59
-37.91%
9.01
-13.59%
10.42
+172.59%
3.82
Interest Expense Non Operating
0.09
-89.10%
0.81
0.00
—
Net Interest Income
5.59
-37.91%
9.01
-13.59%
10.42
+172.59%
3.82
Interest Expense
0.09
-89.10%
0.81
0.00
—
Interest Income Non Operating
5.68
-42.12%
9.81
-5.84%
10.42
+172.59%
3.82
Interest Income
5.68
-42.12%
9.81
-5.84%
10.42
+172.59%
3.82
Other Income Expense
4.79
+193.96%
-5.10
-283.61%
2.78
+195.04%
-2.92
Other Non Operating Income Expenses
1.46
+237.04%
0.43
-51.08%
0.88
+829.75%
-0.12
Gain On Sale Of Security
3.33
+160.28%
-5.53
-392.08%
1.89
+167.61%
-2.80
Tax Provision
0.23
+834.38%
-0.03
-113.11%
0.24
+135.47%
-0.69
Tax Rate For Calcs
0.00
+26150.00%
0.00
-99.62%
0.00
+950.00%
0.00
Tax Effect Of Unusual Items
0.70
+15924.06%
-0.00
-101.11%
0.40
+809.88%
-0.06
Net Income Including Noncontrolling Interests
-45.54
-18.19%
-38.53
-56.90%
-24.56
+25.36%
-32.90
Net Income From Continuing Operation Net Minority Interest
-45.54
-18.19%
-38.53
-56.90%
-24.56
+25.36%
-32.90
Net Income From Continuing And Discontinued Operation
-45.54
-18.19%
-38.53
-56.90%
-24.56
+25.36%
-32.90
Net Income Continuous Operations
-45.54
-18.19%
-38.53
-56.90%
-24.56
+25.36%
-32.90
Normalized Income
-48.17
-45.95%
-33.01
-26.69%
-26.05
+13.61%
-30.16
Net Income Common Stockholders
-45.54
-18.19%
-38.53
-56.90%
-24.56
+25.36%
-32.90
Diluted EPS
—
-1.26
-55.56%
-0.81
+25.00%
-1.08
Basic EPS
—
-1.26
-55.56%
-0.81
+25.00%
-1.08
Basic Average Shares
—
30.46
+0.07%
30.44
0.00%
30.44
Diluted Average Shares
—
30.46
+0.07%
30.44
0.00%
30.44
Diluted NI Availto Com Stockholders
-45.54
-18.19%
-38.53
-56.90%
-24.56
+25.36%
-32.90
Gain On Sale Of PPE
—
—
—
—
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
150.08
-24.62%
199.09
-12.14%
226.62
-7.92%
246.10
Current Assets
126.95
-27.28%
174.57
-13.46%
201.72
-8.24%
219.84
Cash Cash Equivalents And Short Term Investments
125.55
-27.29%
172.68
-13.67%
200.02
-8.03%
217.48
Cash And Cash Equivalents
125.55
-27.29%
172.68
-13.67%
200.02
+27.16%
157.31
Other Short Term Investments
—
—
0.00
-100.00%
60.17
Receivables
0.36
-58.04%
0.86
-8.24%
0.94
-47.00%
1.76
Accounts Receivable
—
—
—
—
Taxes Receivable
0.00
-100.00%
0.16
+110.67%
0.07
-86.31%
0.55
Accrued Interest Receivable
0.36
-48.57%
0.70
-18.60%
0.86
-29.28%
1.22
Prepaid Assets
—
—
—
—
Current Deferred Assets
—
—
—
—
Restricted Cash
—
—
—
—
Other Current Assets
1.04
+0.97%
1.03
+35.79%
0.76
+26.46%
0.60
Total Non Current Assets
23.13
-5.70%
24.53
-1.49%
24.90
-5.19%
26.26
Net PPE
23.13
-5.70%
24.53
-1.49%
24.90
-5.19%
26.26
Gross PPE
44.80
+0.65%
44.51
+3.19%
43.14
+0.89%
42.76
Accumulated Depreciation
-21.67
-8.43%
-19.98
-9.57%
-18.24
-10.57%
-16.50
Properties
0.00
0.00
0.00
0.00
Land And Improvements
1.42
+0.00%
1.42
+0.00%
1.42
+0.00%
1.42
Buildings And Improvements
24.17
+0.00%
24.17
+0.00%
24.17
+0.00%
24.17
Machinery Furniture Equipment
0.73
+0.41%
0.72
+2.12%
0.71
+0.71%
0.70
Construction In Progress
1.79
+5.10%
1.71
+263.54%
0.47
+16.96%
0.40
Other Properties
16.69
+1.20%
16.49
+0.76%
16.37
+1.92%
16.06
Non Current Deferred Assets
—
—
—
—
Non Current Deferred Taxes Assets
—
—
—
—
Total Liabilities Net Minority Interest
9.73
-42.16%
16.82
+116.57%
7.77
+36.27%
5.70
Current Liabilities
7.93
-47.51%
15.11
+147.62%
6.10
+50.02%
4.07
Payables And Accrued Expenses
2.75
-35.25%
4.24
-23.37%
5.54
+54.82%
3.58
Payables
1.61
-27.53%
2.22
-14.47%
2.60
+5.52%
2.46
Accounts Payable
1.53
-30.95%
2.22
-11.65%
2.52
+4.49%
2.41
Current Accrued Expenses
1.14
-43.74%
2.02
-31.24%
2.94
+163.82%
1.11
Pensionand Other Post Retirement Benefit Plans Current
5.18
+747.95%
0.61
+8.72%
0.56
+14.93%
0.49
Total Tax Payable
0.08
0.00
-100.00%
0.08
+50.91%
0.06
Income Tax Payable
0.08
0.00
-100.00%
0.08
+50.91%
0.06
Current Debt And Capital Lease Obligation
—
10.25
—
—
Current Debt
—
10.25
—
—
Other Current Borrowings
—
10.25
—
—
Total Non Current Liabilities Net Minority Interest
1.80
+4.83%
1.72
+3.06%
1.67
+2.08%
1.64
Tradeand Other Payables Non Current
1.80
+4.53%
1.72
+3.06%
1.67
+5.90%
1.58
Non Current Deferred Liabilities
0.01
0.00
0.00
-100.00%
0.06
Non Current Deferred Taxes Liabilities
0.01
0.00
0.00
-100.00%
0.06
Stockholders Equity
140.35
-23.00%
182.27
-16.71%
218.85
-8.97%
240.40
Common Stock Equity
140.35
-23.00%
182.27
-16.71%
218.85
-8.97%
240.40
Capital Stock
276.73
+1.33%
273.11
+0.72%
271.15
+1.43%
267.32
Common Stock
276.73
+1.33%
273.11
+0.72%
271.15
+1.43%
267.32
Preferred Stock
0.00
0.00
0.00
0.00
Share Issued
30.49
+0.00%
30.49
+0.17%
30.44
-0.01%
30.44
Ordinary Shares Number
30.49
+0.00%
30.49
+0.17%
30.44
-0.01%
30.44
Retained Earnings
-136.38
-50.13%
-90.84
-73.66%
-52.31
-88.50%
-27.75
Gains Losses Not Affecting Retained Earnings
—
—
0.00
-100.00%
0.83
Other Equity Adjustments
—
—
—
0.83
Total Equity Gross Minority Interest
140.35
-23.00%
182.27
-16.71%
218.85
-8.97%
240.40
Total Capitalization
140.35
-23.00%
182.27
-16.71%
218.85
-8.97%
240.40
Working Capital
119.02
-25.36%
159.46
-18.48%
195.62
-9.34%
215.78
Invested Capital
140.35
-27.10%
192.52
-12.03%
218.85
-8.97%
240.40
Total Debt
—
10.25
—
—
Net Tangible Assets
140.35
-23.00%
182.27
-16.71%
218.85
-8.97%
240.40
Tangible Book Value
140.35
-23.00%
182.27
-16.71%
218.85
-8.97%
240.40
Interest Payable
0.00
-100.00%
0.40
0.00
—
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-39.92
-28.93%
-30.96
-65.36%
-18.73
-26.32%
-14.82
Cash Flow From Continuing Operating Activities
-39.92
-28.93%
-30.96
-65.36%
-18.73
-26.32%
-14.82
Net Income From Continuing Operations
-45.54
-18.19%
-38.53
-56.90%
-24.56
+25.36%
-32.90
Depreciation Amortization Depletion
1.69
-3.38%
1.75
+0.06%
1.74
-33.28%
2.61
Depreciation
1.69
-3.38%
1.75
+0.06%
1.74
-33.28%
2.61
Depreciation And Amortization
1.69
-3.38%
1.75
+0.06%
1.74
-33.28%
2.61
Stock Based Compensation
3.62
+106.62%
1.75
-46.26%
3.26
-35.56%
5.06
Operating Gains Losses
-3.33
-160.28%
5.53
+392.08%
-1.89
-167.61%
2.80
Net Foreign Currency Exchange Gain Loss
-3.33
-160.28%
5.53
+392.08%
-1.89
-167.61%
2.80
Change In Working Capital
3.65
+349.83%
-1.46
-153.66%
2.72
-64.22%
7.60
Change In Receivables
0.57
+645.45%
0.08
-90.71%
0.83
-88.71%
7.34
Changes In Account Receivables
—
—
—
0.00
Change In Prepaid Assets
-0.01
+96.31%
-0.27
-69.38%
-0.16
-147.90%
0.33
Change In Payables And Accrued Expense
3.08
+343.16%
-1.26
-159.98%
2.11
+184.62%
0.74
Change In Accrued Expense
3.69
+520.30%
-0.88
-146.28%
1.90
+727.51%
0.23
Change In Payable
-0.61
-57.22%
-0.39
-281.31%
0.21
-58.20%
0.51
Change In Account Payable
-0.69
-89.01%
-0.36
-500.00%
0.09
-74.51%
0.36
Change In Other Working Capital
0.01
—
-0.06
+92.76%
-0.81
Investing Cash Flow
-0.29
+77.84%
-1.30
-102.12%
61.50
+196.25%
-63.89
Cash Flow From Continuing Investing Activities
-0.29
+77.84%
-1.30
-102.12%
61.50
+196.25%
-63.89
Net PPE Purchase And Sale
-0.29
+77.84%
-1.30
-260.22%
-0.36
+38.12%
-0.58
Purchase Of PPE
-0.29
+77.84%
-1.30
-260.22%
-0.36
+38.12%
-0.58
Capital Expenditure
-0.29
+77.84%
-1.30
-260.22%
-0.36
+38.12%
-0.58
Net Investment Purchase And Sale
—
0.00
-100.00%
61.86
+197.71%
-63.31
Purchase Of Investment
—
—
—
-63.31
Sale Of Investment
—
0.00
-100.00%
61.86
—
Net Business Purchase And Sale
—
—
—
—
Gain Loss On Sale Of Business
—
—
—
—
Financing Cash Flow
-10.25
-198.09%
10.45
+116211.11%
-0.01
0.00
Cash Flow From Continuing Financing Activities
-10.25
-198.09%
10.45
+116211.11%
-0.01
0.00
Net Issuance Payments Of Debt
-10.25
-200.00%
10.25
0.00
—
Issuance Of Debt
—
10.25
0.00
—
Repayment Of Debt
-10.25
—
—
—
Short Term Debt Issuance
—
10.25
0.00
—
Short Term Debt Payments
-10.25
—
—
—
Net Short Term Debt Issuance
-10.25
-200.00%
10.25
0.00
—
Net Common Stock Issuance
—
—
—
—
Common Stock Dividend Paid
—
—
—
0.00
Cash Dividends Paid
—
—
—
0.00
Proceeds From Stock Option Exercised
0.00
-100.00%
0.20
+3900.00%
0.01
0.00
Net Other Financing Charges
—
—
-0.01
—
Changes In Cash
-50.46
-131.28%
-21.82
-151.02%
42.76
+154.33%
-78.72
Effect Of Exchange Rate Changes
3.33
+160.28%
-5.53
-11919.57%
-0.05
+95.21%
-0.96
Beginning Cash Position
172.68
-13.67%
200.02
+27.16%
157.31
-33.62%
236.98
End Cash Position
125.55
-27.29%
172.68
-13.67%
200.02
+27.16%
157.31
Free Cash Flow
-40.21
-24.61%
-32.27
-69.05%
-19.09
-23.87%
-15.41
Interest Paid Supplemental Data
0.49
+21.50%
0.40
0.00
—
Income Tax Paid Supplemental Data
—
0.09
-38.30%
0.14
—
Change In Income Tax Payable
0.08
+425.00%
-0.02
-119.51%
0.12
-20.65%
0.15
Change In Tax Payable
0.08
+425.00%
-0.02
-119.51%
0.12
-20.65%
0.15
Common Stock Issuance
—
—
—
—
Issuance Of Capital Stock
—
—
—
—
Sale Of Business
—
—
—
—
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category